Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Cardiff Oncology, Inc. (NASDAQ: CRDF) CEO Mani Mohindru purchased 34,364 shares of common stock and an equivalent number of warrants on July 14, 2026. The acquisition, totaling $49,999, comes as the stock trades near its 52-week low. The purchase coincides with a $10 million registered direct offering and recent clinical trial data presentations, d…
Asaf Silberstein, Executive Vice President and Chief Operating Officer at Semtech Corp. (NASDAQ: SMTC), executed a sale of 3,000 shares of the company's common stock on July 14, 2026. The transaction, valued at $435,120, was conducted at a price of $145.04 per share through a family trust. This sale follows a substantial period of stock appreciatio…
Craig Lisowski, President of Products at Nextdoor Holdings, Inc. (NASDAQ:NXDR), executed a series of equity transactions in mid-July 2026. The sales, processed through a Rule 10b5-1 trading plan adopted in September 2025, occurred alongside the vesting of restricted stock units and subsequent tax withholding obligations. These dispositions take pla…
Kevin J. Pearson, Vice Chairman of M&T Bank Corp, executed a transaction involving 2,000 shares of common stock on July 15, 2026. The sale, totaling $484,000, was conducted automatically under a pre-arranged trading plan. This activity occurs as M&T Bank reports record second-quarter financial results, with earnings and revenue exceeding Wall Stree…
FB Financial Corp (NASDAQ:FBK) Chief Accounting Officer Joyce Lynn J completed a share sale totaling $413,210 on July 15, 2026. The transaction involved 7,000 shares sold between $59.00 and $59.10. This activity occurs as the stock trades near its 52-week high of $62.37, with Benchmark recently raising its price target to $67.
Thrivent Financial for Lutherans, recognized as a significant shareholder in Ares Dynamic Credit Allocation Fund, Inc., has formally increased its holdings through a recent acquisition of preferred equity. The transaction underscores the institution's continued allocation to structured credit instruments, with the fund's long-standing dividend hist…
Horizon Kinetics Asset Management LLC has executed a recent purchase of Texas Pacific Land Corp (NYSE:TPL) equity, adding to its existing substantial position. The transaction occurs as the company navigates a period of strong market performance and reports financial results that have exceeded analyst expectations. Market observers are currently as…
Christopher Bohrson, Senior Vice President and Chief Customer Officer at Cohu Inc. (NASDAQ: COHU), executed a stock sale totaling $57,920 on July 15, 2026, in accordance with a pre-arranged 10b5-1 trading plan. The transaction involved the disposition of 1,000 shares at $57.92 per share, reducing his direct holdings to 170,702 shares, including 109…
Gregory Stephen Smith, President and CEO of Teradyne, Inc. (NASDAQ: TER), executed a sale of 4,000 shares on July 15, 2026, under a Rule 10b5-1 plan established in February 2026. The transaction, valued at $1,425,240, occurs as the company's stock retreats from its sale price of $356.31 to $323.41, with analysis suggesting the stock may be trading …
Marilyn Matz, a director at Teradyne, Inc. (NASDAQ:TER), recently sold 1,200 shares of the company's common stock, resulting in a total transaction value of $427,572. The sale was executed on July 15, 2026, at a price of $356.31 per share, under a Rule 10b5-1 sales plan adopted on February 13, 2026. Following the transaction, Matz directly holds 16…
Stephen F. Page, a director at AeroVironment Inc. (NASDAQ:AVAV), has executed a sale of company shares valued at $35,464. The transaction, conducted through a pre-arranged trading plan, reduces the indirect holdings of the Stephen F. Page Living Trust. The sale occurs against a backdrop of mixed analyst sentiment and recent operational developments…
Horizon Kinetics Asset Management LLC has executed a new purchase of RENN Fund, Inc. shares, according to a recent Form 4 filing submitted to the Securities and Exchange Commission. The transaction underscores the firm's continued financial engagement with the fund, which it advises and holds a significant ownership stake in. The purchase adds to H…
Phreesia, Inc. (NASDAQ: PHR) director Lisa Egbuonu-Davis sold 536 shares of the company's common stock on July 14, 2026, totaling $5,735 at a price of $10.70 per share. The transaction was executed under a Rule 10b5-1 trading plan adopted on December 16, 2025. Following the sale, Egbuonu-Davis directly holds 37,780 shares of Phreesia. The stock cur…
UMH Properties director Mitchell William Edward acquired 67.80 shares on July 15, 2026, through the company's Dividend Reinvestment and Stock Purchase Plan. The transaction occurred at $14.75 per share, totaling $1,000, which was priced below the contemporaneous market rate of $15.67. This purchase brings Edward's direct holdings to 34,133.27 share…
Kevin S. Miller, who serves as Executive Vice President, Chief Financial Officer, and Treasurer at UMH Properties, Inc. (NASDAQ: UMH), has executed a share purchase, adding to his direct holdings in the real estate investment trust. This transaction occurs against a backdrop of significant corporate developments, including a recent leadership appoi…
Jan Gommaar M. Vleugels, Chief Operating Officer - International at Alliance Laundry Holdings Inc. (NASDAQ: ALH), sold 75,000 shares of common stock on July 15, 2026. The transaction, valued at $1,905,000, was executed under a Rule 10b5-1 trading plan established on March 16, 2026. The sale occurred as the stock traded near $25.32, reflecting a 24%…
Gregg Williams, a director and significant shareholder in Vivani Medical, Inc. (NASDAQ: VANI), completed a $999,999 purchase of 793,650 shares on July 15, 2026. The transaction, structured as a private sale under an agreement dated August 11, 2025, aligns with the company's recent corporate developments and clinical progress. Williams' acquisition …
Anixa Biosciences Inc. (NASDAQ:ANIX) director Lewis H. Titterton Jr. executed a purchase of 2,797 common shares on July 15, 2026, at $3.28 per share. The acquisition brings his direct holdings to 974,967 shares. The biotech firm continues to advance its clinical pipeline, including a Phase 1 CAR-T therapy for ovarian cancer and a breast cancer vacc…
Richard Chen, serving as both President and Chief Medical Officer at Personalis, Inc. (NASDAQ: PSNL), executed a significant divestment of company equity on July 15, 2026. The transaction involved the sale of 100,000 shares, generating proceeds of $1,515,000. This activity was facilitated by a Rule 10b5-1 trading plan adopted in late December 2025,…
Alclear Investments, LLC, a key shareholder and director of Clear Secure, Inc. (NASDAQ: YOU), executed a significant sale of Class A common stock totaling approximately $5.38 million on July 13, 2026. The transaction, conducted under a pre-existing Rule 10b5-1 trading plan, involved the liquidation of 100,757 shares at prices ranging from $53.00 to…
Clear Secure Inc. (NASDAQ: YOU) Chief Executive Officer Caryn Seidman Becker completed a significant divestment of 100,757 Class A common shares, realizing approximately $5.38 million in proceeds. The transaction, executed on July 13, 2026, was part of a Rule 10b5-1 trading plan established in March 2026. This sale follows a period of robust stock …
Thrivent Financial for Lutherans, a notable shareholder in Gloo Holdings, Inc. (GLOO), executed a series of sales involving 190,000 shares of Class A Common Stock between July 13 and July 15, 2026. The divestment, totaling $634,838 in aggregate value, occurred while the stock traded around $3.36, marking a significant 58% decline over the previous …
Sheena Jonathan, co-founder and director at Natera Inc., liquidated $836,898 worth of Natera common stock on July 13, 2026. The transaction involved the sale of 3,150 shares priced between $262.716 and $268.387 per share. This activity was executed under a Rule 10b5-1 plan established on December 12, 2025. Following the sale, Jonathan retains direc…
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Chief Medical Officer Rodman David Malcom executed two separate sales of company common stock totaling $556,671 on July 13 and July 15, 2026. The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan established on October 6, 2025. Concurrently with the initial sale on July 13, Mr. Malc…
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) CEO Jon Congleton executed a sale of 10,700 shares of the company's common stock on July 13, 2026, totaling $291,441. The transaction, conducted through a Rule 10b5-1 trading plan adopted in January 2025, saw shares sold at prices between $26.80 and $27.58. This sale reduces Congleton's direct holdings but…
